PULMATRIX, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
PULMATRIX, INC. (PULM) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 3-month period ending 2026-03-31, per its S-4/A filed 2026-08-03.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-09-17
- PULMATRIX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 0.00 shares.
- PULMATRIX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2019-12-31 was 0.00 shares.
- PULMATRIX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2019-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- PULMATRIX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2019-06-30 was 651.60K shares, a 90.28% decline year-over-year.
- PULMATRIX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2019 was 651.60K shares, a 3.34% decline from fiscal 2018.
- PULMATRIX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2018 was 674.10K shares, a 38.46% decline from fiscal 2017.
- PULMATRIX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2017 was 1.10M shares, a 43.21% increase from fiscal 2016.
- PULMATRIX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2016 was 764.85K shares, a 53.15% decline from fiscal 2015.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | 0.00 shares S-4/A · filed 2026-08-03 | ||||
| 2025-12-31 | 0.00 shares S-4/A · filed 2026-09-17 | ||||
| 2024-12-31 | 0.00 shares S-4/A · filed 2026-09-17 | ||||
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | 0.00 shares derived: sum of 2 quarters · filed 2020-03-26 | 651.60K shares derived: sum of 3 quarters · filed 2020-03-26 | 651.60K shares 10-K · filed 2020-03-26 | |
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | 651.60K shares derived: sum of 2 quarters · filed 2019-11-01 | 651.60K shares 10-Q · filed 2019-11-01 | -5.42M shares derived: sum of 4 quarters · filed 2019-11-01 | |
| 2019-06-30 | 651.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | 651.60K shares 10-Q · filed 2019-08-05 | -5.42M shares derived: sum of 3 quarters · filed 2019-08-05 | -5.38M shares derived: sum of 4 quarters · filed 2019-08-05 | |
| 2019-03-31 | 0.00 shares 10-Q · filed 2019-05-15 | -6.07M shares derived: sum of 2 quarters · filed 2019-05-15 | -6.03M shares derived: sum of 3 quarters · filed 2019-05-15 | 674.10K shares derived: sum of 4 quarters · filed 2019-05-15 | |
| 2018-12-31 | -6.07M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | -6.03M shares derived: sum of 2 quarters · filed 2019-02-19 | 674.10K shares derived: sum of 3 quarters · filed 2019-02-19 | 674.10K shares 10-K · filed 2019-02-19 | |
| 2018-09-30 | 34.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | 6.74M shares derived: sum of 2 quarters · filed 2018-11-14 | 6.74M shares 10-Q · filed 2018-11-14 | 7.11M shares derived: sum of 4 quarters · filed 2018-11-14 | |
| 2018-06-30 | 6.71M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | 6.71M shares 10-Q · filed 2018-08-03 | 7.07M shares derived: sum of 3 quarters · filed 2018-08-03 | 7.09M shares derived: sum of 4 quarters · filed 2018-08-03 | |
| 2018-03-31 | 0.00 shares 10-Q · filed 2018-05-11 | 364.00K shares derived: sum of 2 quarters · filed 2018-05-11 | 379.00K shares derived: sum of 3 quarters · filed 2018-05-11 | 729.80K shares derived: sum of 4 quarters · filed 2018-05-11 | |
| 2017-12-31 | 364.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | 379.00K shares derived: sum of 2 quarters · filed 2018-03-13 | 729.80K shares derived: sum of 3 quarters · filed 2018-03-13 | 1.10M shares 10-K · filed 2018-03-13 | |
| 2017-09-30 | 15.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 365.80K shares derived: sum of 2 quarters · filed 2017-11-09 | 731.36K shares 10-Q · filed 2017-11-09 | 739.86K shares derived: sum of 4 quarters · filed 2017-11-09 | |
| 2017-06-30 | 350.80K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | 716.36K shares 10-Q · filed 2017-08-04 | 724.86K shares derived: sum of 3 quarters · filed 2017-08-04 | 733.65K shares derived: sum of 4 quarters · filed 2017-08-04 | |
| 2017-03-31 | 365.56K shares 10-Q · filed 2017-05-05 | 374.06K shares derived: sum of 2 quarters · filed 2017-05-05 | 382.86K shares derived: sum of 3 quarters · filed 2017-05-05 | 385.86K shares derived: sum of 4 quarters · filed 2017-05-05 | |
| 2016-12-31 | 8.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | 17.30K shares derived: sum of 2 quarters · filed 2017-03-10 | 20.30K shares derived: sum of 3 quarters · filed 2017-03-10 | 764.85K shares 10-K · filed 2017-03-10 | |
| 2016-09-30 | 8.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | 11.80K shares derived: sum of 2 quarters · filed 2016-11-04 | 756.35K shares 10-Q · filed 2016-11-04 | 848.65K shares derived: sum of 4 quarters · filed 2016-11-04 | |
| 2016-06-30 | 3.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | 747.55K shares 10-Q · filed 2016-08-04 | 839.85K shares derived: sum of 3 quarters · filed 2016-08-04 | 1.08M shares derived: sum of 4 quarters · filed 2016-08-04 | |
| 2016-03-31 | 744.55K shares 10-Q · filed 2016-05-05 | 836.85K shares derived: sum of 2 quarters · filed 2016-05-05 | 1.08M shares derived: sum of 3 quarters · filed 2016-05-05 | 2.38M shares derived: sum of 4 quarters · filed 2016-05-05 | |
| 2015-12-31 | 92.30K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | 333.44K shares derived: sum of 2 quarters · filed 2016-03-10 | 1.63M shares derived: sum of 3 quarters · filed 2016-03-10 | 1.63M shares 10-K · filed 2016-03-10 | |
| 2015-09-30 | 241.14K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | 1.54M shares derived: sum of 2 quarters · filed 2016-03-10 | 1.54M shares 10-Q · filed 2015-11-12 | 1.54M shares derived: sum of 4 quarters · filed 2016-03-10 | |
| 2015-06-30 | 1.30M shares derived: 10-K 12 month − 3 quarters · filed 2016-03-10 | 1.30M shares 10-Q · filed 2015-08-14 | 1.30M shares derived: sum of 3 quarters · filed 2016-03-10 | 1.30M shares derived: sum of 4 quarters · filed 2016-03-10 | |
| 2015-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-10 | 0.00 shares derived: sum of 2 quarters · filed 2015-06-10 | 0.00 shares derived: sum of 3 quarters · filed 2015-06-10 | 332.50K shares 10-K · filed 2015-06-10 | |
| 2014-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-13 | 0.00 shares derived: sum of 2 quarters · filed 2015-02-13 | 332.50K shares 10-Q · filed 2015-02-13 | ||
| 2014-09-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-13 | 332.50K shares 10-Q · filed 2014-11-13 | |||
| 2014-06-30 | 332.50K shares 10-Q · filed 2014-08-14 | ||||
| 2014-05-12 | 332.50K shares 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |